CyclophosphamideCystadenomaAntineoplastic Combined Chemotherapy ProtocolsDoxorubicinBreast NeoplasmsChemotherapy, AdjuvantCombined Modality TherapyAntineoplastic Agents, AlkylatingTreatment OutcomeAntineoplastic AgentsCisplatinPhosphoramide MustardsEtoposideMethotrexateVincristineDrug Administration ScheduleDisease-Free SurvivalSurvival AnalysisPrednisoneSurvival RateNeoadjuvant TherapyThiotepaNeoplasm StagingImmunosuppressive AgentsPrognosisLymphoma, Non-HodgkinTransplantation, AutologousIfosfamideCarboplatinGranulocyte Colony-Stimulating FactorPaclitaxelLeukopeniaPrednisolonePulse Therapy, DrugLung NeoplasmsAntibodies, Monoclonal, Murine-DerivedBleomycinBusulfanCarmustineHematopoietic Stem Cell TransplantationEpirubicinTaxoidsBone Marrow TransplantationFollow-Up StudiesVinblastineDose-Response Relationship, DrugNeutropeniaMelphalanTime FactorsCytarabineNeoplasm Recurrence, LocalNeoplasmsVidarabineMitoxantroneInduction ChemotherapySalvage TherapyRecurrenceVomitingRemission InductionAnthracyclinesDrug Resistance, NeoplasmNeoplasm MetastasisFluorouracilNauseaWhole-Body IrradiationMesnaHodgkin DiseaseOvarian NeoplasmsAdministration, MetronomicProspective StudiesInfusions, IntravenousClinical Trials as TopicAntimetabolites, AntineoplasticDeoxycytidineTransplantation ConditioningChlorambucilAntibiotics, AntineoplasticCystitisLomustineLymphoma, Large B-Cell, DiffuseMethylprednisoloneHematopoietic Stem Cell MobilizationOrganoplatinum CompoundsAntineoplastic Agents, PhytogenicLymphatic MetastasisThrombocytopeniaAntibodies, MonoclonalDexamethasoneLymphomaRadiotherapy, AdjuvantAdenocarcinomaDrug Therapy, CombinationImmunosuppressionTesticular NeoplasmsLeukocyte CountDacarbazineAntiemeticsKaplan-Meier EstimateRadiotherapyNeoplasms, Germ Cell and Embryonal